# Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

> **NCT02260882** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 243 (actual)

## Conditions studied

- Pneumococcal Infection

## Interventions

- **BIOLOGICAL:** PNEUMOVAX™ 23

## Key facts

- **NCT ID:** NCT02260882
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-31
- **Primary completion:** 2015-04-09
- **Final completion:** 2015-04-09
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02260882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02260882, "Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02260882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*